C-REACTIVE PROTEIN ABNORMAL

This adverse event was reported 1248 times

These drugs are most commonly taken by patients reporting C-REACTIVE PROTEIN ABNORMAL:

# Drug Count
0 ETANERCEPT 875
1 METHOTREXATE SODIUM 783
2 ADALIMUMAB 695
3 ABATACEPT 594
4 METHOTREXATE 584
5 TOCILIZUMAB 496
6 SULFASALAZINE 460
7 LEFLUNOMIDE 457
8 TOFACITINIB 396
9 HYDROXYCHLOROQUINE SULFATE 379
See all common drugs associated with C-REACTIVE PROTEIN ABNORMAL

C-REACTIVE PROTEIN ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OXYCODONE HYDROCHLORIDE AND IBUPROFEN 1 0.1667
1 COMMON DANDELION 2 0.1429
2 DARIFENACIN HYDROBROMIDE 20 0.0500
3 ANTIBACTERIAL HAND SOAP 5 0.0476
4 BORIC ACID 4 0.0426
5 GOLD 56 0.0395
6 RHO (D) IMMUNE GLOBULIN 9 0.0345
7 DESOXIMETASONE 33 0.0207
8 ANAKINRA 69 0.0161
9 SULFASALAZINE 460 0.0156
See all drugs enriched for association with C-REACTIVE PROTEIN ABNORMAL

C-REACTIVE PROTEIN ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nonsteroidal Anti-inflammatory Drug [EPC] 340 0.0005
1 Prostaglandin Analog [EPC] 20 0.0004
2 Tetracycline-class Drug [EPC] 3 0.0001
3 Angiotensin Converting Enzyme Inhibitor [EPC] 5 0.0001
4 Vitamin B6 Analog [EPC] 1 0.0000
5 Insulin Analog [EPC] 7 0.0000
See all drug classes enriched for association with C-REACTIVE PROTEIN ABNORMAL